Clinical trial
Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters
NCT00431665 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00431665 |
|---|---|
| Title | Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters |
| Official title | Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Renal Circulation, Renal Plasma Flow, Glomerular Filtration Rate, Fatty Acids, Nonesterified |
| Intervention type | Drug |
| Interventions | NG-monomethyl-L-Arginine (L-NMMA), triglycerides (Intralipid 20%), heparin, somatostatin, insulin, glucose, inulin, paraamino hippurate (PAH) |
| Enrollment | 9 |
| Start date | Jul 1, 1999 |
| Completion | Jun 1, 2000 |
| First posted | Feb 6, 2007 |
| Last update posted | Feb 6, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: